Treating Erectile Dysfunction in Diabetes Patients
- 1 February 1997
- journal article
- review article
- Published by SAGE Publications in The Diabetes Educator
- Vol. 23 (1) , 29-38
- https://doi.org/10.1177/014572179702300103
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Prostaglandin E1 Versus Mixture of Prostaglandin E1, Papaverine and Phentolamine in Nonresponders to High Papaverine Plus Phentolamine DosesJournal of Urology, 1996
- Treatment of the Intraoperative Penile Erection with Intracavernous PhenylephrineJournal of Urology, 1995
- Chart for Preparation of Dilutions of Alpha-Adrenergic Agonists for Intracavernous Use in Treatment of PriapismJournal of Urology, 1995
- The Lowest Effective Dose of Prostaglandin E1 as Treatment for Erectile DysfunctionJournal of Urology, 1995
- Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection.Journal of Clinical Investigation, 1993
- Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: intracavernous injection of prostaglandin E1Published by American Medical Association (AMA) ,1991
- ImpotenceNew England Journal of Medicine, 1989
- Noninvasive device to produce and maintain an erection-like stateUrology, 1986
- IS IMPOTENCE AN ARTERIAL DISORDER?The Lancet, 1985
- HYPERPROLACTINAEMIA AND IMPOTENCEClinical Endocrinology, 1978